Małgorzata Borowiak

Prof. UAM, dr hab. Małgorzata Borowiak is Leader of the Stem Cell and Regenerative Medicine Program at Adam Mickiewicz University (UAM) in Poznań, Poland. Her research focuses on the directed differentiation of human pluripotent stem cells (hPSCs) into pancreatic beta cells, iPSC-based disease modeling, and the transcriptional and mechanosignaling networks governing endocrine progenitor development. She trained as a postdoctoral fellow with Doug Melton at Harvard University and subsequently led an independent research group at Baylor College of Medicine (Houston, TX) as a McNair Scholar before joining UAM. Her foundational work on  pancreatic fate induction has been published in Nature, Cell Stem Cells, Nature Biotechnology, and Nature Chemical Biology, and she is co-inventor on patents licensed to Vertex Pharmaceuticals and StemCell Technologies. She currently leads a multi-investigator team supported by the Foundation for Polish Science (FNP TEAM-NET) and participates in the NIH RADIANT consortium on atypical and neonatal diabetes. Her laboratory applies high-throughput Perturb-seq screening and single-cell transcriptomics to unravel gene regulatory mechanisms in human beta cell differentiation and maturation. In 2025, she was awarded the Tadeusz Browicz Prize by the Polish Academy of Arts and Sciences (PAU) in recognition of her contributions to biomedical research.